Is UBS Group AG (UBS) a risky stock?
As of July 25, 2026, Clavix grades UBS Group AG (UBS) B- for risk, a composite score of 70 out of 100 on an A+ to F scale, which puts UBS in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 25, 2026. Clavix regrades every trading day.
UBS price, last 3 months
UBS's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind UBS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how UBS scores on each, as of July 25, 2026.
What's moving UBS's risk right now
Company-specific signals Clavix flags behind UBS's current grade, drawn from recent news and filings as of July 25, 2026.
Tenet Healthcare's (THC) Q2 results topped expectations, with both its hospital and ambulatory surge
UBS said Amkor’s expanded $1.5-billion partnership with Nvidia strengthens its position in packaging next-generation AI chips and could support future growth.
Pending regulatory outcomes could shift materially in either direction, keeping uncertainty elevated in the risk premium.
Recent UBS news
The latest headlines Clavix ingested for UBS Group AG, newest first. These feed the news-sentiment dimension of UBS's grade.
What a B- grade means
On the Clavix A+ to F scale, UBS's composite of 70 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell UBS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.